Based in Oxford, U.K., Exscientia designs and discovers new drugs using artificial intelligence, and received a $4.2 million grant company received recently from the Bill & Melinda Gates Foundation.
Exscientia Receives A $4.2 Million Grant From The Gates Foundation To Develop New Medicines And Treatments For Infectious Diseases
